Longitudinal course of depression symptoms in multiple sclerosis.

Journal of Neurology, Neurosurgery, and Psychiatry
P A Arnett, J J Randolph

Abstract

Despite the high lifetime prevalence of depression in multiple sclerosis (MS), its longitudinal course is poorly understood. To examine the longitudinal course of and reliable change in different depression symptom clusters in MS, and the longitudinal association of interferon beta treatment and coping with depression symptoms. 53 MS patients were examined at two time points three years apart on the Beck Depression Inventory (BDI) and the Chicago Multiscale Depression Inventory (CMDI). Correlations from time 1 to time 2 for BDI, CMDI-total, CMDI-evaluative scale, and CMDI-vegetative scale were all highly significant, and reliable change indices reflected little change over time. In contrast, the correlation over time for the CMDI-mood scale was significantly lower (p<0.05) than the CMDI-evaluative and CMDI-vegetative scale correlations, and over 40% of patients showed reliable change. Patients who improved in their mood showed increased use of active coping, while patients who worsened showed decreased active coping strategies; the latter were also significantly more likely to have been taking interferon beta drugs at both time points than patients who did not change in their mood functioning. Mood symptoms of depression are si...Continue Reading

References

Jun 1, 1992·Journal of Consulting and Clinical Psychology·D C Speer
Feb 1, 1991·Journal of Consulting and Clinical Psychology·N S Jacobson, P Truax
Feb 1, 1989·Journal of Personality and Social Psychology·C S CarverJ K Weintraub
Dec 1, 1987·Journal of Consulting and Clinical Psychology·F W FoleyM Reznikoff
Mar 1, 1983·Annals of Neurology·C M PoserW W Tourtellotte
Jul 1, 1994·Psychological Bulletin·J C Coyne
Mar 1, 1996·Neurology·A D SadovnickD W Paty
May 1, 1995·Journal of the International Neuropsychological Society : JINS·D L NyenhuisD C Garron
Jan 1, 1997·Psychotherapy and Psychosomatics·S B Patten, L M Metz
Jul 26, 2002·Journal of Neurology·Anthony FeinsteinKaren Feinstein
Sep 10, 2002·Journal of Psychosomatic Research·Karlein M G SchreursJozien M Bensing
Sep 11, 2002·Neurology·Scott B PattenUNKNOWN SPECTRIMS Study Group
Feb 28, 2003·The Clinical Neuropsychologist·Peter A ArnettAlicia A Grandey
Feb 28, 2003·The Clinical Neuropsychologist·Ralph H B BenedictFrederick Munschauer

❮ Previous
Next ❯

Citations

Jun 19, 2008·Journal of Neurology·Charlotte YtterbergLena von Koch
Sep 4, 2008·Journal of the International Neuropsychological Society : JINS·Peter A ArnettJoe E Beeney
Sep 22, 2010·Nature Reviews. Neurology·Rex D Simmons
Jul 9, 2008·Journal of Clinical and Experimental Neuropsychology·Michael R BassoJay Johnson
Apr 27, 2013·Health and Quality of Life Outcomes·Karine BaumstarckPascal Auquier
Jan 24, 2014·International Journal of MS Care·Stephen S KirzingerAndrew Bryce Crush
Aug 13, 2014·Nature Reviews. Neurology·Anthony FeinsteinCraig Moore
Jun 30, 2014·Neurochemical Research·Monika Adamczyk-SowaMarcin Hartel
Sep 23, 2014·Autoimmunity Reviews·Mariana Postal, Simone Appenzeller
Jan 14, 2016·Journal of Clinical and Experimental Neuropsychology·Cristina A F Roman, Peter A Arnett
Sep 18, 2012·Journal of Psychosomatic Research·Phil MooreNeil P Robertson
Jan 13, 2016·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M SantoroD Quaranta
May 25, 2010·Physical Medicine and Rehabilitation Clinics of North America·Charles H BombardierIvan R Molton
Mar 27, 2009·Patient Education and Counseling·Julie BarlowMollie Gilchrist
Jan 21, 2016·Multiple Sclerosis International·Maria Josè MessinaVittorio Martinelli
Jan 27, 2009·Clinical Psychology Review·Laura DennisonTrudie Chalder
Dec 17, 2008·Journal of Psychosomatic Research·Yvonne BolFrans R J Verhey
Nov 21, 2007·Clinical Neurology and Neurosurgery·Maria José Sá
Aug 4, 2007·Archives of Psychiatric Nursing·Claudia C BealAdama Brown
Aug 30, 2008·Psychology and Psychotherapy·R F BrownJ D Pollard
Jan 26, 2013·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·K BaumstarckUNKNOWN MusiQoL study group
Nov 1, 2013·Acta Neurologica Scandinavica·V BianchiC Pozzilli
Mar 22, 2014·Brain and Behavior·Khadija ChahraouiThibault Moreau
May 31, 2011·Journal of the Neurological Sciences·Andrea GiordanoUNKNOWN SIMS-Trial group
Nov 5, 2014·International Journal of Psychiatry in Clinical Practice·Pinar G OzdemirAbdullah Atli
Jul 28, 2015·Contemporary Nurse·Somayeh GhafariEesa Mohammadi
Jun 5, 2015·Multiple Sclerosis : Clinical and Laboratory Research·Marie ThéaudinAnthony Feinstein
Sep 27, 2013·Multiple Sclerosis : Clinical and Laboratory Research·Ipek EnsariAnthony Feinstein
Nov 8, 2007·Multiple Sclerosis : Clinical and Laboratory Research·S B PattenL M Metz
Oct 22, 2008·Expert Review of Neurotherapeutics·Maria Pia AmatoEmilio Portaccio
Jan 1, 2009·Therapeutic Advances in Neurological Disorders·Ida S HaussleiterGeorg Juckel
Nov 12, 2014·The Journal of Nursing Research : JNR·Masoud Fallahi-KhoshknabEesa Mohammadi
Jan 13, 2018·Journal of Medical Economics·Peter CarneyKillian O'Rourke
Aug 31, 2018·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·T V BaidinaM A Danilova
May 25, 2007·Journal of Psychiatric Practice·Michael G FitzsimonsJack M Gorman
Dec 7, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Joyce C McCann, Bruce N Ames
Apr 10, 2008·The Journal of the Acoustical Society of America·Blaise PotardSlim Ouni
Jan 1, 2008·Language and Speech·David Eddington, Dirk Elzinga

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Multiple Sclerosis : Clinical and Laboratory Research
M Korostil, Anthony Feinstein
Journal of Neurology, Neurosurgery, and Psychiatry
R J Siegert, D A Abernethy
Multiple Sclerosis : Clinical and Laboratory Research
D C KroenckeS G Lynch
© 2022 Meta ULC. All rights reserved